nahaleh naraqi

Actoverco Pharmaceutical Company

Selected nahaleh naraqi

4R4A0525

Actover Pharmaceutical Group Showcases Its Neurology Portfolio at the 32nd Iranian Congress of Neurology and Clinical Electrophysiology

روز کارگر-EN-08

Labor Day Tribute from Actoverco

عید فطر - تلگرام - انگلیسی -04

Eid al-Fitr: A Celebration of Faith, Renewal, and Prosperity

4R4A68781-2048x1365

First AcTrip Conference Held to Address Hypothyroidism Screening, Diagnosis, and Treatment

4R4A061511-2048x1365

Atipharmed Supports the 6th International Congress on Minimally Invasive Techniques in Gynecology and Endometriosis

Visit of neurologists and psychologists from Actoverco Pharmaceutical Factories

Actover Group, on the occasion of Doctor’s Day, hosted a group of prominent neurology and psychologist professors of Tehran on Thursday, August 22.

Nahaleh Naraghi

Signing agreement of cooperation and establishment of a new innovation center in the Actoverco company

Signing agreement of cooperation for the establishment of the “Actotech Innovation Center” and the beginning of the official knowledge-based activities in the Actoverco company was held in the presence of the Vice President for Science and Technology.

Nahaleh Naraghi irán pharma

Actoverco received 90.8 million Euros of governmental currency in the first half of this year

The CEO of Actoverco said: “This Company has received about 90 million and 800 thousand Euros of governmental currency in the first 6 months of the year.”

nahaleh naraghi ceo of actoverco

With the lifting of sanctions, many announced their readiness to work with “Actoverco

We have a program for production of Rituximab and Bevacizumab drugs for cancer patients, ophthalmologists, etc. These drugs are very expensive due to their high technical knowledge, and from next year, we will also produce the raw materials for these drugs ourselves.